跳至主要内容

博文

目前显示的是标签为“Inspection Schedule”的博文

2020.4 NDA/BLA Inspection Schedule by CFDI for NMPA

April 2020 NDA/BLA Inspection Schedule by CFDI for NMPA:

No.Acceptance numberCompanyProducts1CXSS1900005 Xinjiang Deyuan BioengineeringHuman Immunnglnhlobulin (pH4) for Intravenous Injection2CXSS1700033 Shanxi Kangbao BiologicalHuman coagulation factor Ⅷ 3CYHS1900202 Chongqing Huapont PharmAminosalicylate  Enteric-CoatedGranules4CXHS1800035 Yichang Humanwell PharmaRamimazolam Besilate for Injection 5CXSS1800029 Heibei Daan Pharma Human Immunnglnhlobulin (pH4) for Intravenous Injection6Y20190000075 Chongqing Huapont Kaisheng PharmAminosalicylate 7CYSB1800230 Beijing Kawin Technology Recombinant Human Interferon α2b Injection 8CYSB1800229 Beijing Kawin Technology Recombinant Human Interferon α2b Injection9CYSB1800228 Beijing Kawin TechnologyRecombinant Human Interferon α2b Injection10CYSB1800231 Beijing Kawin TechnologyRecombinant Human Interferon α2b Vaginal Effervescent Tablets11CXSS1900029 Heibei Daan Pharma Human Prothrombin Complex 12CXSS1800007 China Biologic Products Human coagul…